List of Tables
Table 1. Global Protein-based Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Antibody-based Drugs
Table 3. Key Players of Fc Fusion Proteins
Table 4. Key Players of Anticoagulants
Table 5. Key Players of Blood Factors
Table 6. Key Players of Other
Table 7. Global Protein-based Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Protein-based Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Protein-based Drug Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Protein-based Drug Market Share by Region (2020-2025)
Table 11. Global Protein-based Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Protein-based Drug Market Share by Region (2026-2031)
Table 13. Protein-based Drug Market Trends
Table 14. Protein-based Drug Market Drivers
Table 15. Protein-based Drug Market Challenges
Table 16. Protein-based Drug Market Restraints
Table 17. Global Protein-based Drug Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Protein-based Drug Market Share by Players (2020-2025)
Table 19. Global Top Protein-based Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Protein-based Drug as of 2024)
Table 20. Ranking of Global Top Protein-based Drug Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Protein-based Drug Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Protein-based Drug, Headquarters and Area Served
Table 23. Global Key Players of Protein-based Drug, Product and Application
Table 24. Global Key Players of Protein-based Drug, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Protein-based Drug Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Protein-based Drug Revenue Market Share by Type (2020-2025)
Table 28. Global Protein-based Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Protein-based Drug Revenue Market Share by Type (2026-2031)
Table 30. Global Protein-based Drug Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Protein-based Drug Revenue Market Share by Application (2020-2025)
Table 32. Global Protein-based Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Protein-based Drug Revenue Market Share by Application (2026-2031)
Table 34. North America Protein-based Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Protein-based Drug Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Protein-based Drug Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Protein-based Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Protein-based Drug Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Protein-based Drug Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Protein-based Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Protein-based Drug Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Protein-based Drug Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Protein-based Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Protein-based Drug Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Protein-based Drug Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Protein-based Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Protein-based Drug Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Protein-based Drug Market Size by Country (2026-2031) & (US$ Million)
Table 49. AbbVie Company Details
Table 50. AbbVie Business Overview
Table 51. AbbVie Protein-based Drug Product
Table 52. AbbVie Revenue in Protein-based Drug Business (2020-2025) & (US$ Million)
Table 53. AbbVie Recent Development
Table 54. Johnson & Johnson Company Details
Table 55. Johnson & Johnson Business Overview
Table 56. Johnson & Johnson Protein-based Drug Product
Table 57. Johnson & Johnson Revenue in Protein-based Drug Business (2020-2025) & (US$ Million)
Table 58. Johnson & Johnson Recent Development
Table 59. Novartis Company Details
Table 60. Novartis Business Overview
Table 61. Novartis Protein-based Drug Product
Table 62. Novartis Revenue in Protein-based Drug Business (2020-2025) & (US$ Million)
Table 63. Novartis Recent Development
Table 64. Gilead Sciences Company Details
Table 65. Gilead Sciences Business Overview
Table 66. Gilead Sciences Protein-based Drug Product
Table 67. Gilead Sciences Revenue in Protein-based Drug Business (2020-2025) & (US$ Million)
Table 68. Gilead Sciences Recent Development
Table 69. Roche Company Details
Table 70. Roche Business Overview
Table 71. Roche Protein-based Drug Product
Table 72. Roche Revenue in Protein-based Drug Business (2020-2025) & (US$ Million)
Table 73. Roche Recent Development
Table 74. Bristol-Myers Squibb Company Details
Table 75. Bristol-Myers Squibb Business Overview
Table 76. Bristol-Myers Squibb Protein-based Drug Product
Table 77. Bristol-Myers Squibb Revenue in Protein-based Drug Business (2020-2025) & (US$ Million)
Table 78. Bristol-Myers Squibb Recent Development
Table 79. Amgen Company Details
Table 80. Amgen Business Overview
Table 81. Amgen Protein-based Drug Product
Table 82. Amgen Revenue in Protein-based Drug Business (2020-2025) & (US$ Million)
Table 83. Amgen Recent Development
Table 84. AstraZeneca Company Details
Table 85. AstraZeneca Business Overview
Table 86. AstraZeneca Protein-based Drug Product
Table 87. AstraZeneca Revenue in Protein-based Drug Business (2020-2025) & (US$ Million)
Table 88. AstraZeneca Recent Development
Table 89. Merck & Co Company Details
Table 90. Merck & Co Business Overview
Table 91. Merck & Co Protein-based Drug Product
Table 92. Merck & Co Revenue in Protein-based Drug Business (2020-2025) & (US$ Million)
Table 93. Merck & Co Recent Development
Table 94. Takeda Company Details
Table 95. Takeda Business Overview
Table 96. Takeda Protein-based Drug Product
Table 97. Takeda Revenue in Protein-based Drug Business (2020-2025) & (US$ Million)
Table 98. Takeda Recent Development
Table 99. Merck KGaA Company Details
Table 100. Merck KGaA Business Overview
Table 101. Merck KGaA Protein-based Drug Product
Table 102. Merck KGaA Revenue in Protein-based Drug Business (2020-2025) & (US$ Million)
Table 103. Merck KGaA Recent Development
Table 104. Seagen Company Details
Table 105. Seagen Business Overview
Table 106. Seagen Protein-based Drug Product
Table 107. Seagen Revenue in Protein-based Drug Business (2020-2025) & (US$ Million)
Table 108. Seagen Recent Development
Table 109. Eli Lilly Company Details
Table 110. Eli Lilly Business Overview
Table 111. Eli Lilly Protein-based Drug Product
Table 112. Eli Lilly Revenue in Protein-based Drug Business (2020-2025) & (US$ Million)
Table 113. Eli Lilly Recent Development
Table 114. Ono Pharmaceutical Company Details
Table 115. Ono Pharmaceutical Business Overview
Table 116. Ono Pharmaceutical Protein-based Drug Product
Table 117. Ono Pharmaceutical Revenue in Protein-based Drug Business (2020-2025) & (US$ Million)
Table 118. Ono Pharmaceutical Recent Development
Table 119. Pfizer Company Details
Table 120. Pfizer Business Overview
Table 121. Pfizer Protein-based Drug Product
Table 122. Pfizer Revenue in Protein-based Drug Business (2020-2025) & (US$ Million)
Table 123. Pfizer Recent Development
Table 124. Regeneron Company Details
Table 125. Regeneron Business Overview
Table 126. Regeneron Protein-based Drug Product
Table 127. Regeneron Revenue in Protein-based Drug Business (2020-2025) & (US$ Million)
Table 128. Regeneron Recent Development
Table 129. Innovent Company Details
Table 130. Innovent Business Overview
Table 131. Innovent Protein-based Drug Product
Table 132. Innovent Revenue in Protein-based Drug Business (2020-2025) & (US$ Million)
Table 133. Innovent Recent Development
Table 134. Hengrui Medicine Company Details
Table 135. Hengrui Medicine Business Overview
Table 136. Hengrui Medicine Protein-based Drug Product
Table 137. Hengrui Medicine Revenue in Protein-based Drug Business (2020-2025) & (US$ Million)
Table 138. Hengrui Medicine Recent Development
Table 139. Sanofi Company Details
Table 140. Sanofi Business Overview
Table 141. Sanofi Protein-based Drug Product
Table 142. Sanofi Revenue in Protein-based Drug Business (2020-2025) & (US$ Million)
Table 143. Sanofi Recent Development
Table 144. Sobi Company Details
Table 145. Sobi Business Overview
Table 146. Sobi Protein-based Drug Product
Table 147. Sobi Revenue in Protein-based Drug Business (2020-2025) & (US$ Million)
Table 148. Sobi Recent Development
Table 149. Kanghong Pharma Company Details
Table 150. Kanghong Pharma Business Overview
Table 151. Kanghong Pharma Protein-based Drug Product
Table 152. Kanghong Pharma Revenue in Protein-based Drug Business (2020-2025) & (US$ Million)
Table 153. Kanghong Pharma Recent Development
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
Table 157. Authors List of This Report
List of Figures
Figure 1. Protein-based Drug Picture
Figure 2. Global Protein-based Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Protein-based Drug Market Share by Type: 2024 VS 2031
Figure 4. Antibody-based Drugs Features
Figure 5. Fc Fusion Proteins Features
Figure 6. Anticoagulants Features
Figure 7. Blood Factors Features
Figure 8. Other Features
Figure 9. Global Protein-based Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Protein-based Drug Market Share by Application: 2024 VS 2031
Figure 11. Immune Diseases Case Studies
Figure 12. Cancer Case Studies
Figure 13. Other Case Studies
Figure 14. Protein-based Drug Report Years Considered
Figure 15. Global Protein-based Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Protein-based Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Protein-based Drug Market Share by Region: 2024 VS 2031
Figure 18. Global Protein-based Drug Market Share by Players in 2024
Figure 19. Global Top Protein-based Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Protein-based Drug as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Protein-based Drug Revenue in 2024
Figure 21. North America Protein-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Protein-based Drug Market Share by Country (2020-2031)
Figure 23. United States Protein-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Protein-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Protein-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Protein-based Drug Market Share by Country (2020-2031)
Figure 27. Germany Protein-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Protein-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Protein-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Protein-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Protein-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Protein-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Protein-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Protein-based Drug Market Share by Region (2020-2031)
Figure 35. China Protein-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Protein-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Protein-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Protein-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Protein-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Protein-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Protein-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Protein-based Drug Market Share by Country (2020-2031)
Figure 43. Mexico Protein-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Protein-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Protein-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Protein-based Drug Market Share by Country (2020-2031)
Figure 47. Turkey Protein-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Protein-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Protein-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. AbbVie Revenue Growth Rate in Protein-based Drug Business (2020-2025)
Figure 51. Johnson & Johnson Revenue Growth Rate in Protein-based Drug Business (2020-2025)
Figure 52. Novartis Revenue Growth Rate in Protein-based Drug Business (2020-2025)
Figure 53. Gilead Sciences Revenue Growth Rate in Protein-based Drug Business (2020-2025)
Figure 54. Roche Revenue Growth Rate in Protein-based Drug Business (2020-2025)
Figure 55. Bristol-Myers Squibb Revenue Growth Rate in Protein-based Drug Business (2020-2025)
Figure 56. Amgen Revenue Growth Rate in Protein-based Drug Business (2020-2025)
Figure 57. AstraZeneca Revenue Growth Rate in Protein-based Drug Business (2020-2025)
Figure 58. Merck & Co Revenue Growth Rate in Protein-based Drug Business (2020-2025)
Figure 59. Takeda Revenue Growth Rate in Protein-based Drug Business (2020-2025)
Figure 60. Merck KGaA Revenue Growth Rate in Protein-based Drug Business (2020-2025)
Figure 61. Seagen Revenue Growth Rate in Protein-based Drug Business (2020-2025)
Figure 62. Eli Lilly Revenue Growth Rate in Protein-based Drug Business (2020-2025)
Figure 63. Ono Pharmaceutical Revenue Growth Rate in Protein-based Drug Business (2020-2025)
Figure 64. Pfizer Revenue Growth Rate in Protein-based Drug Business (2020-2025)
Figure 65. Regeneron Revenue Growth Rate in Protein-based Drug Business (2020-2025)
Figure 66. Innovent Revenue Growth Rate in Protein-based Drug Business (2020-2025)
Figure 67. Hengrui Medicine Revenue Growth Rate in Protein-based Drug Business (2020-2025)
Figure 68. Sanofi Revenue Growth Rate in Protein-based Drug Business (2020-2025)
Figure 69. Sobi Revenue Growth Rate in Protein-based Drug Business (2020-2025)
Figure 70. Kanghong Pharma Revenue Growth Rate in Protein-based Drug Business (2020-2025)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
